New Independent Clinical Study Demonstrates Safety and Effectiveness of GC Aesthetics PERLE Breast Implant

GC Aesthetics® (GCA), a privately held medical technology company providing aesthetic and reconstructive solutions for global healthcare markets, is proud to announce that its PERLE™ breast implant is featured in a recent independent peer-reviewed article in the Aesthetic Surgery Journal Open Forum. Led by Mr. Taimur Shoaib (United Kingdom), the study highlights the safety and performance of PERLE, the round opaque breast implant with the unique Bio-Q™ surface and 6th generation gel .

This is the first time that clinical data on PERLE has been published in an international journal, thus proving the safety and performance of this breast implant.

A group of 374 patients was analyzed retrospectively, with an average follow-up duration of 18 months. The study highlights low complication rates when using PERLE™ implants.

“I conducted this study to evaluate the safety of PERLE implants. We rolled out these implants at my clinic, La Belle Forme in Glasgow, in early 2021 when I learned about the scientific approach behind them. Every empirical aspect of the implant matched my idea of ​​what a high-quality implant should be, and I wanted to test it. We followed 374 patients, with PERLE implants, over an average of 18 months. Our study showed that the safety profile of these implants is comparable to other modern implants, with no implant-related complications or cases of capsular contracture,” emphasizes Mr. Taimur Shoaib.

This independent clinical study validates the quality and safety of PERLE breast implants, thus meeting the standards and expectations of surgeons and patients.

Chris Brotherston, Head of Quality, Regulatory and Clinical Affairs at GC Aesthetics, said: “This is not only a significant milestone for GC Aesthetics; it is also validation of our commitment to safety and obtaining exceptional results. We are also proud to announce the launch of our 10-year prospective study of PERLE in the first quarter of 2024, to continue to collect critical data and strengthen its safety and compatibility profile. »

Find the full article here: Zhi Yang Ng, Calum Honeyman, Taimur Shoaib, Single-Institution Early Experience With a New, Smooth, Opaque, and Round Breast Implant Over a 2-Year Period, Aesthetic Surgery Journal Open Forum , Volume 5, 2023, ojad090,

About GC Aesthetics®

GC Aesthetics® is a long-established global medical technology company that develops, manufactures and markets a full range of proprietary aesthetic and reconstructive products.

Over its 40-year history, GCA® has been committed to advancing the science of medical aesthetics and providing high-quality breast implants for breast augmentation and reconstructive breast surgery. We have sold more than 3 million implants in 70 countries and our products are supported by 10 years of published clinical data.

The text of the press release resulting from a translation should in no way be considered official. The only authentic version of the press release is that of the press release in its original language. The translation must always be compared with the source text, which will set a precedent.

Source Link

Newsletter Updates

Enter your email address below and subscribe to our newsletter